Prehospital Academy Lesson 12.7
Paramedic Medication Classes: Cardiac Medications
Introduction
Welcome back to our advanced pharmacology series, this lesson focusses on medications critical for cardiac management in the prehospital setting. As paramedics, a comprehensive understanding of these drugs is paramount for addressing a wide array of cardiovascular emergencies, from dysrhythmias to hypertension and heart failure. We will explore their classifications, mechanisms of action, and essential considerations for safe and effective administration. Remember, always adhere to your local protocols and standing orders, and consult online medical control when patient presentation deviates from standard guidelines.
Antiarrhythmic Medications: Regulating the Heart's Rhythm
Antiarrhythmic medications are designed to target specific cells within the heart to resolve dysrhythmias (abnormal heart rhythms) or suppress ectopic foci – electrical activity originating from anywhere other than the heart's natural pacemaker, the SA node. The Vaughan Williams classification system categorizes these drugs into four main classes based on their primary mechanism of action:
Class I: Sodium Channel Blockers (e.g., Procainamide, Lidocaine)
These medications slow the movement of sodium into cardiac cells. Lidocaine, for instance, directly blocks sodium channels to resolve ventricular dysrhythmias and suppress ectopic foci. Procainamide also suppresses ectopic activity and slows conduction velocity.Class II: Beta-Adrenergic Blocking Agents (Beta-Blockers) (e.g., Metoprolol, Labetalol)
Beta-blockers inhibit the activation of beta-receptor sites by catecholamines (e.g., adrenaline). They can block both beta-1 (primarily cardiac) and beta-2 (primarily pulmonary/vascular) receptors, depending on the specific drug and dose. Metoprolol, a common beta-blocker, reduces heart rate during myocardial ischemia and atrial tachycardias, decreasing myocardial oxygen demand. Caution is advised when administering with calcium channel blockers due to the potential for severe conduction abnormalities.Class III: Potassium Channel Blockers (e.g., Amiodarone, Sotalol)
These medications prolong the absolute refractory period of cardiac cells, meaning the time during which the cell cannot be re-stimulated. Amiodarone is widely used for both atrial and ventricular tachycardias. It's important to administer amiodarone slowly, especially in conscious patients with a pulse, to avoid adverse cardiovascular and pulmonary effects, unless the patient is in cardiac arrest.Class IV: Calcium Channel Blockers (e.g., Diltiazem, Verapamil)
Calcium channel blockers control heart rate and blood pressure by displacing calcium at receptor sites or inhibiting its entry into smooth muscle cells. Diltiazem (Cardizem) is a common choice for controlling heart rate in patients with atrial fibrillation and atrial flutter. It decreases the automaticity of cardiac muscle and ectopic foci, as well as the force and speed of cardiac contraction. Continuous ECG and frequent blood pressure monitoring are crucial during administration.
Other Key Cardiac Medications
Adenosine: This unique medication decreases cardiac conduction velocity and prolongs the effective refractory period, resulting in a brief period of electrical silence (asystole). It has a very rapid onset and brief duration, making it useful for treating supraventricular tachycardias (SVTs). It must be administered rapidly through a proximal IV, followed by a saline flush.
Alpha-Adrenergic Receptor Antagonists (Alpha-Blockers) (e.g., Labetalol): These prevent endogenous catecholamines from binding to alpha receptors, leading to lower blood pressure and decreased systemic vascular resistance. Labetalol is a common alpha-1, beta-1, and beta-2 antagonist used frequently in prehospital settings for hypertensive emergencies.
Angiotensin-Converting Enzyme (ACE) Inhibitors (e.g., Lisinopril): ACE inhibitors alter the renin-angiotensin system, leading to decreased blood pressure and cardiac afterload. Patients on ACE inhibitors may develop a chronic dry cough or, in rare but life-threatening cases, angioedema (swelling of the face and tongue) which requires emergent airway management.
Anticholinergic Medications (e.g., Atropine): Atropine antagonizes the parasympathetic nervous system (cholinergic system). It is used to treat symptomatic bradycardia, especially when vagal stimulation is suspected, and can be a life-saving antidote for organophosphate poisoning.
Catecholamines and Sympathomimetics (e.g., Epinephrine, Norepinephrine, Dopamine, Dobutamine): These agents stimulate the sympathetic nervous system. Epinephrine is a powerful stimulant of alpha, beta-1, and beta-2 receptors, used in cardiac arrest, anaphylaxis, and severe asthma. Norepinephrine is a potent vasoconstrictor for severe hypotension. Dopamine and Dobutamine are primarily used to improve cardiac contractility and manage hypotension refractory to fluid resuscitation.
Vasodilator Medications (e.g., Nitroglycerin, Sodium Nitroprusside): These medications dilate blood vessels. Nitroglycerin dilates veins and coronary arteries, relieving chest pain and decreasing blood pressure. Sodium nitroprusside is a potent IV vasodilator for hypertensive emergencies.
Diuretic Medications (e.g., Furosemide): Used to correct fluid overload, manage congestive heart failure, and improve respiration in pulmonary edema. Paramedics must use caution and consult medical control due to the potential for electrolyte disturbances and paradoxical effects in patients with fluid shifts (e.g., third-spacing where fluid is in interstitial spaces but intravascularly dehydrated).
Critical Thinking Questions
A patient presents with a rapid heart rate and a narrow QRS complex on the ECG, unresponsive to vagal maneuvers. Which antiarrhythmic medication would a paramedic likely administer, and what is its expected effect on the heart's electrical activity?
You are managing a patient in cardiogenic shock with persistent hypotension despite initial fluid challenges. What class of medications might be considered to improve cardiac output and systemic vascular resistance, and what are the primary receptors they target?
A patient on a new ACE inhibitor develops sudden facial and tongue swelling. What is this condition, and what immediate airway management considerations should the paramedic prioritize?
Describe the careful balance a paramedic must maintain when administering diuretics to a patient with suspected pulmonary edema. What fluid compartments are being considered, and why is electrolyte monitoring crucial?
Contrast the mechanisms of action between a Class II (beta-blocker) and a Class IV (calcium channel blocker) antiarrhythmic medication. How do these differences influence their respective uses in cardiac emergencies?